Establishment of MicroRNA delivery system by PP7 bacteriophage-like particles carrying cell-penetrating peptide

Yanli Sun1, Yanhua Sun2, Ronglan Zhao1

  • 1Institute of Nanomedicine Technology, Department of Laboratory Medicine, Institutional Key Laboratory of Clinical Laboratory Diagnostics, 12th 5-Year Project of Shandong Province, Key Discipline of Clinical Laboratory Medicine of Shandong Province, Affiliated Hospital of Weifang Medical University, Weifang Medical University, Weifang 261053, China.

Insights

Recombinant bacteriophage virus-like particles (VLPs) offer a novel method for delivering microRNAs (miRNAs) into cancer cells. These engineered VLPs protect miRNAs from degradation and enhance cellular uptake, showing potential for targeted cancer therapy.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Nanomedicine

Background:

  • MicroRNAs (miRNAs) show therapeutic promise but face challenges with instability and inefficient in vivo delivery.
  • Existing delivery methods, including viral and non-viral vectors, have limitations.

Purpose of the Study:

  • To develop a novel delivery system for microRNAs using recombinant PP7 bacteriophage virus-like particles (VLPs).
  • To enhance microRNA delivery efficiency and stability for potential therapeutic applications in cancer treatment.

Main Methods:

  • Engineered recombinant PP7 bacteriophage-based VLPs to package specific exogenous pre-microRNAs via the pac site.
  • Incorporated a cell-penetrating peptide (CPP) into the VLP structure to improve mammalian cell penetration.
  • Utilized a one-plasmid double expression system in Escherichia coli for efficient VLP production.
  • Tested the delivery of pre-microRNA-23b into hepatoma SK-HEP-1 cells and assessed its therapeutic effect.

Main Results:

  • PP7 VLPs carrying a CPP successfully delivered pre-microRNA-23b into hepatoma cells, with mature miRNA processed within 24 hours.
  • A concentration of 10 nM PP7 VLPs with CPP inhibited hepatoma cell migration by downregulating liver-intestine cadherin expression.
  • The engineered PP7 VLPs demonstrated no infectious, replicative, or cytotoxic effects.

Conclusions:

  • Recombinant PP7 VLPs with CPP provide a stable and efficient platform for targeted microRNA and peptide delivery.
  • This system overcomes limitations of traditional delivery methods and shows potential for simultaneous delivery of therapeutic payloads.
  • The non-infectious, non-replicative, and non-cytotoxic nature of these VLPs supports their safety for therapeutic development.

Related Concept Videos

DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
709
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.6K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K